LianBio | Evaluate

Swift resolution emerges to China's non-compliance

January 13, 2022

After a record year, where next for biopharma flotations?

2021 was a huge year for IPOs, with pure-play developers raising $14bn, but 2022 is likely to tell a different story.

January 07, 2021

Covid or not, venture financing breaks records

Private biotechs attracted more venture cash in 2020 than in any other year of the current cycle.